Search - tctmd.com

Displaying 601 - 620 of 627

Sort: Relevancy | Date

Presentation TCT 2012

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Presenter: Martyn Thomas

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(4)

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

DC Devices: Interatrial Shunt for HFPEF

Presenter: Ted Feldman

October 23, 2012

Presentation TCT 2012

CVRx: Results in Heart Failure

Presenter: William Little

October 23, 2012

Presentation TCT 2012

CRT Applicability in Key Subgroups: Earlier (NYHA I/II), Later (NYHA IV), and Female Patients

Presenter: Kimberly Selzman

October 23, 2012

Presentation TCT 2012

Counterpulsation with SYMPHONY for Chronic Heart Failure

Presenter: Robert Dowling

October 23, 2012

Presentation TCT 2012

Counterpulsation for Chronic Heart Failure: Sunshine

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

CorAssist

Presenter: Mitchell Krucoff

October 23, 2012

Presentation TCT 2012

Contemporary LVAD Therapy: Destination, Recovery, Bridge?

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

CircuLite for Patients with INTERMACS 4, 5, and 6

Presenter: Daniel Burkhoff

October 23, 2012

Presentation TCT 2012

Circulatory Support for Cardiogenic Shock

Presenter: E. Magnus Ohman

October 23, 2012

Presentation TCT 2012

BioVentrix Minimally Invasive Reshaping of the Anterior Infarcted Heart

Presenter: Lon Annest

October 23, 2012

Presentation TCT 2012

BioControl

Presenter: Spencer Kubo

October 23, 2012

Presentation TCT 2012

Background Medical and Device Therapies for Patients with VADs

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Transcatheter Interatrial Shunt for Heart Failure with Preserved Ejection Fraction (HFPEF)

Presenter: Brad Munt

October 22, 2012

Presentation TCT 2012

The Emergence of Interventional Heart Failure and Advanced Cardiac Support as an Important Clinical Subspecialty: Clinical Targets, Device Concepts, and Physician Training

Presenter: Navin Kapur

October 22, 2012

Presentation TCT 2012

CHF and Cardiomyopathy

Presenter: Michael Kim

October 21, 2012

Presentation TCT 2012

The impact of revascularization and optimal medical therapy on six-month clinical outcome in patients with and without congestive heart failure after acute myocardial infarction

Presenter: Jang Hoon Lee, Kyun Hee Kim, Won Suk Choi, Sun Hee Park, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Shung Chull Chae, Jae Eun Jun, Myung Ho Jeong, Young Jo Kim

January 03, 2012

Advertisement

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(4)

DC Devices: Interatrial Shunt for HFPEF

CVRx: Results in Heart Failure

CRT Applicability in Key Subgroups: Earlier (NYHA I/II), Later (NYHA IV), and Female Patients

Counterpulsation with SYMPHONY for Chronic Heart Failure

Counterpulsation for Chronic Heart Failure: Sunshine

CorAssist

Contemporary LVAD Therapy: Destination, Recovery, Bridge?

CircuLite for Patients with INTERMACS 4, 5, and 6

Circulatory Support for Cardiogenic Shock

BioVentrix Minimally Invasive Reshaping of the Anterior Infarcted Heart

BioControl

Background Medical and Device Therapies for Patients with VADs

Autologous Cardiac Stem Cells in VAD Patients

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Transcatheter Interatrial Shunt for Heart Failure with Preserved Ejection Fraction (HFPEF)

The Emergence of Interventional Heart Failure and Advanced Cardiac Support as an Important Clinical Subspecialty: Clinical Targets, Device Concepts, and Physician Training

CHF and Cardiomyopathy

The impact of revascularization and optimal medical therapy on six-month clinical outcome in patients with and without congestive heart failure after acute myocardial infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content